Overview of Cancer Immunotherapies

Welcome to the HESI ITC On-demand training course. We are delighted that you have chosen to enhance your educational journey in immuno-safety science by enrolling in this course. The "Overview of Cancer Immunotherapies" course is 1 of 10 courses included in the Cancer Immuno
Category
Format
Credits
- Participation
Cytokine Release Syndrome

The "Cytokine Release " course is 1 of 10 courses included in the Cancer Immunotherapies Module and is led by Dr. Madeline Fort, PhD- at Amgen
Category
Format
Credits
Assessing Risk of Adverse Pregnancy Outcomes for Immuno-Oncology Programs

The "Assessing Risk of Adverse Pregnancy Outcomes for Immuno-Oncology Programs" is 1 of 10 courses included in the Cancer Immunotherapies module. This course is led by
Category
Format
Credits
Nonclinical Safety assessment of therapies targeting neoantigens

The "Nonclinical Safety assessment of therapies targeting neoantigens" is 1 of 10 courses included in the Cancer Immunotherapies module. This course is led by Dr. Gautham Rao at Genentech
Category
Format
- Video
Credits
- Participation
Quantitative systems pharmacology/ toxicology modeling for IO therapies

The "Quantitative systems pharmacology /toxicology modeling for IO therapies" is 1 of 10 courses included in the Cancer Immunotherapies module. This course is led by Dr. Roy song at Glaxo Smith Kline
Category
Format
Credits
Neurotoxicity across Cancer Modalities

The "Neurotoxicity across Cancer Modalities" course is 1 of 10 courses included in the Cancer Immunotherapies module. This course is led by Dr. Juliane Gust, MD at Seattle Children Hospital
Category
Format
Credits
Regulatory Considerations for Cancer Immunotherapies: Preclinical Focus

The "Regulatory Considerations for Cancer Immunotherapies: Preclinical Focus" course is one of 18 course in the Introduction to Immuno- Safety Science. This course is led by Dr. Mary Ellen Cosenza, Ph.D. DABT, ERT, RAC, ATS - at Toxicology consulting.
Category
Format
Credits
Natural Killer Cells and their use for Cancer Immunotherapy

The "Natural Killer Cells and their for Cancer Immunotherapy " course is 1 of 10 courses included in the Cancer Immunotherapies Module and is led by Dr. Alexandre Iannello - at Sonoma Biotherapeutics
Category
Format
Credits
HESI Human health and Safety

Welcome to the HESI ITC On-demand training course. We are delighted that you have chosen this introduction module to start or enhance your current educational journey in immuno-safety science.This course is 1 of 18 courses included in the Introduction to Immuno-Safety
Category
Format
Credits
- Participation
Pages
- « first
- ‹ previous
- 1
- 2
- 3